$UTMD
UTAH MEDICAL PRODUCTS INC Stock $utmd

$utmd Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000181188424000009 Filed on March 26, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$11.34M	$12.33M	$50.22M
YoY Change	-9.42%	-9.15%	-3.93%
Cost Of Revenue	$4.574M	$5.235M	$20.19M
YoY Change	-2.2%	-0.23%	0.5%
Gross Profit	$6.766M	$7.098M	$30.04M
YoY Change	-13.73%	-14.76%	-6.7%
Gross Profit Margin	59.66%	57.55%	59.81%
Selling, General & Admin	$2.617M	$3.008M	$5.380M
YoY Change	-19.72%	-4.02%	-54.84%
% of Gross Profit	38.68%	42.38%	17.91%
Research & Development	$266.0K	$146.0K	$560.0K
YoY Change	84.72%	18.7%	13.59%
% of Gross Profit	3.93%	2.06%	1.86%
Depreciation & Amortization	$156.0K	$1.025M	$6.315M
YoY Change	0.65%	-41.02%	931.86%
% of Gross Profit	2.31%	14.44%	21.02%
Operating Expenses	$2.883M	$3.154M	$11.60M
YoY Change	-15.31%	-3.16%	-6.49%
Operating Profit	$3.883M	$3.944M	$18.44M
YoY Change	-12.53%	-22.21%	-6.84%
Interest Expense		$3.036M	$3.036M
YoY Change		359.3%	359.3%
% of Operating Profit		76.98%	16.47%
Other Income/Expense, Net	$915.0K	-$1.963M	$276.0K
YoY Change	34.56%	1302.14%	46.81%
Pretax Income	$4.798M	$5.017M	$20.09M
YoY Change	-6.27%	-10.27%	-2.76%
Income Tax	$842.0K	$731.0K	$3.454M
% Of Pretax Income	17.55%	14.57%	17.19%
Net Earnings	$3.956M	$4.286M	$16.64M
YoY Change	-6.12%	-5.91%	0.98%
Net Earnings / Revenue	34.89%	34.75%	33.12%
Basic Earnings Per Share	$1.09		$4.58
Diluted Earnings Per Share	$1.09	$1.18	$4.57
COMMON SHARES
Basic Shares Outstanding	3.589M shares	3.630M shares	3.629M shares
Diluted Shares Outstanding	3.618M shares		3.637M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$93.81M	$92.87M	$92.87M
YoY Change	15.94%	23.74%	23.74%
Cash & Equivalents	$93.81M	$92.87M	$92.87M
Short-Term Investments
Other Short-Term Assets	$510.0K	$428.0K	$428.0K
YoY Change	15.38%	-16.89%	-16.89%
Inventory	$9.240M	$9.582M	$9.582M
Prepaid Expenses
Receivables	$3.591M	$3.391M	$3.337M
Other Receivables	$0.00	$0.00	$54.00K
Total Short-Term Assets	$107.1M	$106.3M	$106.3M
YoY Change	12.66%	18.18%	18.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.27M	$10.55M	$10.55M
YoY Change	0.24%	3.2%	3.2%
Goodwill	$13.64M	$13.69M
YoY Change	1.01%	2.53%
Intangibles	$4.388M	$4.946M
YoY Change	-50.78%	-52.34%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$28.29M	$29.19M	$29.19M
YoY Change	-13.37%	-14.04%	-14.04%
TOTAL ASSETS
Total Short-Term Assets	$107.1M	$106.3M	$106.3M
Total Long-Term Assets	$28.29M	$29.19M	$29.19M
Total Assets	$135.4M	$135.5M	$135.5M
YoY Change	6.0%	9.35%	9.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$998.0K	$769.0K	$769.0K
YoY Change	-2.92%	-36.86%	-36.86%
Accrued Expenses	$4.476M	$3.941M	$3.614M
YoY Change	-11.3%	-16.89%	-17.96%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.474M	$4.710M	$4.710M
YoY Change	-9.88%	-20.97%	-20.97%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$698.0K	$993.0K	$993.0K
YoY Change	-44.43%	-37.82%	-37.82%
Total Long-Term Liabilities	$698.0K	$993.0K	$993.0K
YoY Change	-44.43%	-37.82%	-37.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.474M	$4.710M	$4.710M
Total Long-Term Liabilities	$698.0K	$993.0K	$993.0K
Total Liabilities	$7.699M	$7.145M	$7.145M
YoY Change	-21.05%	-25.73%	-25.73%
SHAREHOLDERS EQUITY
Retained Earnings	$139.0M	$138.3M
YoY Change	7.62%	9.79%
Common Stock	$36.00K	$630.0K
YoY Change	-89.94%	119.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$127.7M	$128.3M	$128.3M
YoY Change
Total Liabilities & Shareholders Equity	$135.4M	$135.5M	$135.5M
YoY Change	6.0%	9.35%	9.35%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$3.956M	$4.286M	$16.64M
YoY Change	-6.12%	-5.91%	0.98%
Depreciation, Depletion And Amortization	$156.0K	$1.025M	$6.315M
YoY Change	0.65%	-41.02%	931.86%
Cash From Operating Activities	$5.276M	$5.331M	$22.28M
YoY Change	-23.7%	-6.14%	5.36%
INVESTING ACTIVITIES
Capital Expenditures	$22.00K	$89.00K	$639.0K
YoY Change	-48.84%	134.21%	-21.01%
Acquisitions
YoY Change
Other Investing Activities	$27.00K
YoY Change
Cash From Investing Activities	$5.000K	-$89.00K	-$639.0K
YoY Change	-111.63%	134.21%	-21.88%
FINANCING ACTIVITIES
Cash Dividend Paid	$1.089M		$4.282M
YoY Change	1.78%		35.38%
Common Stock Issuance & Retirement, Net			$117.0K
YoY Change			-94.96%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$3.983M	-1.075M	-4.165M
YoY Change	279.69%	16.85%	-24.05%
NET CHANGE
Cash From Operating Activities	$5.276M	5.331M	22.28M
Cash From Investing Activities	$5.000K	-89.00K	-639.0K
Cash From Financing Activities	-$3.983M	-1.075M	-4.165M
Net Change In Cash	$940.0K	4.167M	17.48M
YoY Change	-83.96%	-11.75%	24.14%
FREE CASH FLOW
Cash From Operating Activities	$5.276M	$5.331M	$22.28M
Capital Expenditures	$22.00K	$89.00K	$639.0K
Free Cash Flow	$5.254M	$5.242M	$21.64M
YoY Change	-23.54%	-7.09%	6.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#FiniteLivedIntangibleAssetsGross
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#FiniteLivedIntangibleAssetsGross
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-12575
CY2023	dei	Entity Registrant Name EntityRegistrantName	UTAH MEDICAL PRODUCTS INC
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	UT
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0342734
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	7043 South 300 West
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Midvale
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84047
CY2023	dei	City Area Code CityAreaCode	801
CY2023	dei	Local Phone Number LocalPhoneNumber	566-1200
CY2023	dei	Security12b Title Security12bTitle	Common stock, $0.01 par value
CY2023	dei	Trading Symbol TradingSymbol	UTMD
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	313392922	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3589014	shares
CY2023	dei	Auditor Name AuditorName	Haynie & Company
CY2023	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2023	dei	Auditor Firm AuditorFirmId	457
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	92868000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	75052000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3391000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5538000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	9582000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8814000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	428000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	515000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	106269000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	89919000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10551000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10224000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	13692000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	13354000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	54296000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	52755000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	49350000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	42378000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4946000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10377000	usd
CY2023Q4	us-gaap	Assets Assets	135458000	usd
CY2022Q4	us-gaap	Assets Assets	123874000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	769000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1218000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3941000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4742000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4710000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5960000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	295000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	341000	usd
CY2023Q4	us-gaap	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability Noncurrent TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent	698000	usd
CY2022Q4	us-gaap	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability Noncurrent TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent	1256000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1120000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1514000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	322000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	549000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	7145000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	9620000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3630000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3630000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3628000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3628000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	36000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	36000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Before Tax1 AccumulatedOtherComprehensiveIncomeLossBeforeTax1	-10658000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Before Tax1 AccumulatedOtherComprehensiveIncomeLossBeforeTax1	-12039000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	594000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	251000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	138341000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	126006000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	128313000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	114254000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	135458000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	123874000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50224000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	52281000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	49054000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	20186000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	20085000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	18137000	usd
CY2023	us-gaap	Gross Profit GrossProfit	30038000	usd
CY2022	us-gaap	Gross Profit GrossProfit	32196000	usd
CY2021	us-gaap	Gross Profit GrossProfit	30917000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1685000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1507000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1414000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	560000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	493000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	526000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11016000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10406000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10097000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	16777000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	19790000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	18880000	usd
CY2023	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	3036000	usd
CY2022	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	661000	usd
CY2021	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	166000	usd
CY2023	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	20000	usd
CY2022	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	20000	usd
CY2021	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	15000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	256000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	188000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20089000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20659000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	19061000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3454000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4186000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4273000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	16635000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	16473000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	14788000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.58
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.53
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.05
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.57
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.52
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.04
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1381000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2986000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-773000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	18016000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13487000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14015000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	16635000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	16473000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	14788000	usd
CY2023	us-gaap	Depreciation Depreciation	623000	usd
CY2022	us-gaap	Depreciation Depreciation	612000	usd
CY2021	us-gaap	Depreciation Depreciation	636000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5692000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6417000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6645000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-33000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	30000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	24000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	53000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	53000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	3000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-693000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-401000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-92000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	225000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	183000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	166000	usd
CY2023	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	12000	usd
CY2022	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	6000	usd
CY2021	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	39000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2270000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	511000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1088000	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	14000	usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	42000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	670000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2353000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	485000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-45000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	64000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	81000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-456000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	464000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-23000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1422000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	252000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	713000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	22281000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	21147000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	21203000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	639000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	809000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	552000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	9000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-639000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-818000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-552000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	117000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	174000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	560000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2495000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	4282000	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	3163000	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	11465000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4165000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5484000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10905000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	339000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-767000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-362000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17816000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14078000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9384000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	75052000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60974000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51590000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	92868000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	75052000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60974000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	4827000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	4970000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	4617000	usd
CY2023	us-gaap	Interest Paid InterestPaid	0	usd
CY2022	us-gaap	Interest Paid InterestPaid	0	usd
CY2021	us-gaap	Interest Paid InterestPaid	0	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	102822000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	787000	usd
CY2021	fil	Common Stock Received And Retired Upon Exercise Of Stock Options CommonStockReceivedAndRetiredUponExerciseOfStockOptions	-227000	usd
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	166000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-773000	usd
CY2021	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	10425000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	14788000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	107138000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	211000	usd
CY2022	fil	Common Stock Received And Retired Upon Exercise Of Stock Options CommonStockReceivedAndRetiredUponExerciseOfStockOptions	-37000	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	183000	usd
CY2022	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-2495000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2986000	usd
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	4233000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	16473000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	114255000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	117000	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	225000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1381000	usd
CY2023	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	4300000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	16635000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	128313000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font:10pt Times New Roman;margin:0"><span style="border-bottom:1px solid #000000">Use of Estimates in the Preparation of Financial Statements</span></p> <p style="font:10pt Times New Roman;margin:0"> </p> <p style="font:10pt Times New Roman;margin:0">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although actual results could differ from those estimates, management believes it has considered and disclosed all relevant information in making its estimates that materially affect reported performance and current values.</p>
CY2023Q4	fil	Foreign Currency Exchange Rate Translation Gb Pto Usd ForeignCurrencyExchangeRateTranslationGBPtoUSD	1.2739	pure
CY2023Q4	fil	Foreign Currency Exchange Rate Translation Au Dto Usd ForeignCurrencyExchangeRateTranslationAUDtoUSD	0.6825	pure
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1931000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1931000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	422000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	10000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	8000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	225000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	183000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	166000	usd
CY2023Q4	us-gaap	Litigation Reserve LitigationReserve	257000	usd
CY2022Q4	us-gaap	Litigation Reserve LitigationReserve	204000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3629000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3637000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3647000	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	8000	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	6000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	13000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3637000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3643000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3660000	shares
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3488000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	5720000	usd
CY2023Q4	us-gaap	Interest Receivable And Other Assets InterestReceivableAndOtherAssets	53000	usd
CY2022Q4	us-gaap	Interest Receivable And Other Assets InterestReceivableAndOtherAssets	51000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	151000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	182000	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	3390000	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	5589000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1685000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1896000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1503000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1193000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	6394000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5725000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	9582000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8814000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	13354000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	14098000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	338000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-744000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q4	us-gaap	Goodwill Goodwill	13692000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	13354000	usd
CY2023Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	2209000	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	2198000	usd
CY2023Q4	us-gaap	Finite Lived Noncompete Agreements Gross FiniteLivedNoncompeteAgreementsGross	127000	usd
CY2022Q4	us-gaap	Finite Lived Noncompete Agreements Gross FiniteLivedNoncompeteAgreementsGross	121000	usd
CY2023Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	9360000	usd
CY2022Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	8887000	usd
CY2023Q4	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	9108000	usd
CY2022Q4	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	8635000	usd
CY2023Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	21000000	usd
CY2022Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	21000000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	342000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	395000	usd
CY2023Q4	fil	Finite Lived Regulatory Approvals And Product Certifications Gross FiniteLivedRegulatoryApprovalsAndProductCertificationsGross	12150000	usd
CY2022Q4	fil	Finite Lived Regulatory Approvals And Product Certifications Gross FiniteLivedRegulatoryApprovalsAndProductCertificationsGross	11519000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	54296000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	52755000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	49350000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	42378000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4946000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10377000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	327000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	337000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1294000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1318000	usd
CY2023Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	257000	usd
CY2022Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	204000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2063000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2883000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3941000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4742000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12520000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12866000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12505000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12333000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	7843000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	7739000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	7359000	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	7098000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	4214000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	4200000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	3935000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	4287000	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.16
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.15
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.08
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.18
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12323000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13428000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12955000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13575000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	7533000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	8151000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	8186000	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	8327000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	3534000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	4103000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	4280000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	4555000	usd
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.96
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.12
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.18
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.25
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10964000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12604000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12572000	usd
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12914000	usd
CY2021Q1	us-gaap	Gross Profit GrossProfit	6947000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	7785000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	8073000	usd
CY2021Q4	us-gaap	Gross Profit GrossProfit	8112000	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	3024000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	3426000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	4206000	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	4131000	usd
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.83
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.94
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.15
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.13
CY2023Q4	us-gaap	Land Land	1638000	usd
CY2022Q4	us-gaap	Land Land	1593000	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	13907000	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	13601000	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	17315000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	17068000	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1413000	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	906000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	34273000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	33168000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23722000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22944000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10551000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10224000	usd
CY2023Q4	us-gaap	Land Land	1638000	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	13907000	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	17315000	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1413000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	34273000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23722000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10551000	usd
CY2022Q4	us-gaap	Land Land	1593000	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	13601000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	17068000	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	906000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	33168000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22944000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10224000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	0	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	0	usd
CY2023	fil	Litigation Expense LitigationExpense	1660000	usd
CY2022	fil	Litigation Expense LitigationExpense	670000	usd
CY2021	fil	Litigation Expense LitigationExpense	22000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	0	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	110000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	103000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	88000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	31000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	39000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	31000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	90000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	90000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	58000	usd
CY2023Q4	fil	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	1673000	usd
CY2022Q4	fil	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	2295000	usd
CY2021Q4	fil	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	2859000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1442000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2063000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2682000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4075000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4632000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3983000	usd
CY2023	fil	Deferred Income Tax Expense DeferredIncomeTaxExpense	-621000	usd
CY2022	fil	Deferred Income Tax Expense DeferredIncomeTaxExpense	-446000	usd
CY2021	fil	Deferred Income Tax Expense DeferredIncomeTaxExpense	290000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3454000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4186000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4273000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2346000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2620000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2520000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	439000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	490000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	448000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	951000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1129000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1010000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	3000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	3000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	6000	usd
CY2023	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	195000	usd
CY2022	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	0	usd
CY2021	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	0	usd
CY2023	fil	Adjustment To Deferred Tax Liability AdjustmentToDeferredTaxLiability	0	usd
CY2022	fil	Adjustment To Deferred Tax Liability AdjustmentToDeferredTaxLiability	0	usd
CY2021	fil	Adjustment To Deferred Tax Liability AdjustmentToDeferredTaxLiability	-391000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-84000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-50000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-90000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3454000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4186000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4273000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	11170000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	12475000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	12004000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	8919000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	8184000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	7057000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20089000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20659000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	19061000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	285000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	84000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	19000	shares
CY2023	fil	Price Range Per Share Granted PriceRangePerShareGranted	77.07 - 77.07
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	400	shares
CY2023	fil	Price Range Per Share Expired PriceRangePerShareExpired	77.05 - 77.05
CY2023	fil	Price Range Per Share Exercised PriceRangePerShareExercised	49.18 - 77.05
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	84000	shares
CY2023	fil	Price Range Per Share Outstanding PriceRangePerShareOutstanding	49.18 - 82.60
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	50000	shares
CY2023	fil	Price Range Per Share Total Exercisable PriceRangePerShareTotalExercisable	49.18 - 82.60
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	21000	shares
CY2022	fil	Price Range Per Share Granted PriceRangePerShareGranted	82.60 - 82.60
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	2000	shares
CY2022	fil	Price Range Per Share Expired PriceRangePerShareExpired	33.30 - 77.05
CY2022	fil	Price Range Per Share Exercised PriceRangePerShareExercised	33.30 - 77.05
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	67000	shares
CY2022	fil	Price Range Per Share Outstanding PriceRangePerShareOutstanding	33.30 - 77.05
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	40000	shares
CY2022	fil	Price Range Per Share Total Exercisable PriceRangePerShareTotalExercisable	33.30 - 77.05
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2021	fil	Price Range Per Share Granted PriceRangePerShareGranted	- - -
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	3000	shares
CY2021	fil	Price Range Per Share Expired PriceRangePerShareExpired	74.64 - 77.05
CY2021	fil	Price Range Per Share Exercised PriceRangePerShareExercised	26.52 - 77.05
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	52000	shares
CY2021	fil	Price Range Per Share Outstanding PriceRangePerShareOutstanding	33.30 - 77.05
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	34000	shares
CY2021	fil	Price Range Per Share Total Exercisable PriceRangePerShareTotalExercisable	33.30 - 77.05
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	12000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	6000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	39000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	225000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	183000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	166000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0.309	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0.305	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3167	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.2987	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0475	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0409	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y7M6D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M12D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	25.09
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	25.34
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	702000	usd
CY2023Q4	fil	Employee Service Share Based Compensation Nonvested Awards Compensation Cost Not Yet Recognized To Be Recognized Over The Next Twelve Months EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedToBeRecognizedOverTheNextTwelveMonths	225000	usd
CY2023	fil	Employee Service Share Based Compensation Nonvested Awards Compensation Cost Not Yet Recognized To Be Recognized Over The Next Twelve Months Period For Recognition EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedToBeRecognizedOverTheNextTwelveMonthsPeriodForRecognition	P12M
CY2023Q4	fil	Employee Service Share Based Compensation Nonvested Awards Compensation Cost Not Yet Recognized To Be Recognized Over The Next Four Years EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedToBeRecognizedOverTheNextFourYears	477	usd
CY2023	fil	Employee Service Share Based Compensation Nonvested Awards Compensation Cost Not Yet Recognized To Be Recognized Over The Next Four Years Period For Recognition EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedToBeRecognizedOverTheNextFourYearsPeriodForRecognition	P4Y
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	49.18
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	82.6
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	84301	shares
CY2023Q4	fil	Weighted Average Remaining Contractual Life Years WeightedAverageRemainingContractualLifeYears	6.79	pure
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	74.56
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	48485	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	70.95
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	31000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	141000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	591000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	814000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1812000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1595000	usd
CY2023	fil	Company Sales In The United States CompanySalesInTheUnitedStates	30413000	usd
CY2022	fil	Company Sales In The United States CompanySalesInTheUnitedStates	34524000	usd
CY2021	fil	Company Sales In The United States CompanySalesInTheUnitedStates	31758000	usd
CY2023	fil	Company Sales In Europe CompanySalesInEurope	8918000	usd
CY2022	fil	Company Sales In Europe CompanySalesInEurope	7214000	usd
CY2021	fil	Company Sales In Europe CompanySalesInEurope	7434000	usd
CY2023	fil	Company Sales Other CompanySalesOther	10893000	usd
CY2022	fil	Company Sales Other CompanySalesOther	10543000	usd
CY2021	fil	Company Sales Other CompanySalesOther	9862000	usd
CY2023Q4	fil	Long Lived Assets In The United States LongLivedAssetsInTheUnitedStates	11462000	usd
CY2022Q4	fil	Long Lived Assets In The United States LongLivedAssetsInTheUnitedStates	14875000	usd
CY2021Q4	fil	Long Lived Assets In The United States LongLivedAssetsInTheUnitedStates	19104000	usd
CY2023Q4	fil	Long Lived Assets In England LongLivedAssetsInEngland	13838000	usd
CY2022Q4	fil	Long Lived Assets In England LongLivedAssetsInEngland	15184000	usd
CY2021Q4	fil	Long Lived Assets In England LongLivedAssetsInEngland	19339000	usd
CY2023Q4	fil	Long Lived Assets In Ireland LongLivedAssetsInIreland	2963000	usd
CY2022Q4	fil	Long Lived Assets In Ireland LongLivedAssetsInIreland	2954000	usd
CY2021Q4	fil	Long Lived Assets In Ireland LongLivedAssetsInIreland	2990000	usd
CY2023Q4	fil	Long Lived Assets In Australia LongLivedAssetsInAustralia	336000	usd
CY2022Q4	fil	Long Lived Assets In Australia LongLivedAssetsInAustralia	337000	usd
CY2021Q4	fil	Long Lived Assets In Australia LongLivedAssetsInAustralia	392000	usd
CY2023Q4	fil	Long Lived Assets In Canada LongLivedAssetsInCanada	589000	usd
CY2022Q4	fil	Long Lived Assets In Canada LongLivedAssetsInCanada	593000	usd
CY2021Q4	fil	Long Lived Assets In Canada LongLivedAssetsInCanada	653000	usd
CY2023	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	20000	usd
CY2022	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	20000	usd
CY2021	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	15000	usd
CY2023Q4	us-gaap	Contractual Obligation ContractualObligation	4529000	usd
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	184000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	159000	usd
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	165000	usd
CY2023Q4	fil	Lessee Operating Lease For Parking Lot Term Of Contract LesseeOperatingLeaseForParkingLotTermOfContract	P8Y
CY2023Q4	fil	Lessee Operating Lease For Automobile Term Of Contract LesseeOperatingLeaseForAutomobileTermOfContract	P6M
CY2022	fil	Lessee Operating Lease For Parking Lot Adjustment To Lease Payments Required Every Five Years Based On Change In Cpi LesseeOperatingLeaseForParkingLotAdjustmentToLeasePaymentsRequiredEveryFiveYearsBasedOnChangeInCPI	87000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	65000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	64000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	63000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	16635000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	16473000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	342000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	47000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	295000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	342000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	45000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	41000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	42000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	43000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	44000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	125000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	381000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	39000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	342000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y4M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2021	us-gaap	Profit Loss ProfitLoss	14788000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3629000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3637000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3647000	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	8000	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	6000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	13000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3637000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3643000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3660000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.58
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.53
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.05
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.57
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.52
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.04
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001811884-24-000009-index-headers.html	Edgar Link	pending
0001811884-24-000009-index.html	Edgar Link	pending
0001811884-24-000009.txt	Edgar Link	pending
0001811884-24-000009-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
utmd-20231231.htm	Edgar Link	pending
utmd-20231231.xsd	Edgar Link	pending
utmd10k_1.jpg	Edgar Link	pending
utmdex23z2_1.jpg	Edgar Link	pending
utmd_ex10z5.htm	Edgar Link	pending
utmd_ex21.htm	Edgar Link	pending
utmd_ex23z1.htm	Edgar Link	pending
utmd_ex23z2.htm	Edgar Link	pending
utmd_ex31z1.htm	Edgar Link	pending
utmd_ex31z2.htm	Edgar Link	pending
utmd_ex32z1.htm	Edgar Link	pending
utmd_ex32z2.htm	Edgar Link	pending
utmd-20231231_def.xml	Edgar Link	unprocessable
utmd-20231231_lab.xml	Edgar Link	unprocessable
utmd-20231231_pre.xml	Edgar Link	unprocessable
utmd-20231231_htm.xml	Edgar Link	completed
utmd-20231231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UTMD
UTAH MEDICAL PRODUCTS INC Stock $utmd

2024 Q1 Form 10-K Financial Statement

#000181188424000009 Filed on March 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UTMD UTAH MEDICAL PRODUCTS INC Stock $utmd

2024 Q1 Form 10-K Financial Statement

#000181188424000009 Filed on March 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UTMD
UTAH MEDICAL PRODUCTS INC Stock $utmd